TFSA Wealth Plan: The Single Canadian Stock for Million-Dollar Success

Here’s why Kits Eyecare is a top TSX stock that should be on the radar of TFSA investors in October 2025.

| More on:
Key Points
  • Kits Eyecare (TSX:KITS) leverages a digital eyecare platform with significant growth potential, having doubled its shareholder returns since its initial public offering in 2021 and delivering robust Q2 results, highlighted by a 31% revenue increase and consistent positive EBITDA.
  • The company demonstrates strong performance in its eyeglasses segment, with substantial gains in customer acquisition and premium product sales, driven by strategic marketing and enhancements to the customer experience through innovations like OpticianAI.
  • Analysts forecast significant growth in sales and earnings, with the potential for the stock to double over the next 18 months, positioning Kits Eyecare as an attractive investment choice for TFSA holders seeking substantial long-term returns.

The Tax-Free Savings Account (TFSA) is a popular registered account in Canada due to its tax-sheltered status. Any returns generated in a TFSA from qualified investments are exempt from Canada Revenue Agency taxes, making it an ideal choice for investors with a sizable risk appetite.

For instance, Canadian investors should consider owning quality growth stocks in the TFSA to derive market-beating returns over time. In this article, I have identified one such Canadian stock that should be part of your TFSA right now.

a person watches stock market trades

Source: Getty Images

The bull case for this TSX stock

Valued at $575 million by market cap, Kits Eyecare (TSX:KITS) operates a digital eyecare platform in the United States and Canada. It is a vertically integrated digital eyewear brand that offers an extensive range of eyeglasses, sunglasses, contact lenses, and vision care products.

KITS aims to revolutionize the eyewear industry by providing a seamless online shopping experience, fast delivery, and exceptional customer care. The TSX stock went public in early 2021 and has since doubled shareholder returns.

Kits Eyecare delivered record revenue of $49.6 million in Q2, representing a 31% year-over-year increase. It reported an adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $2.6 million, indicating a margin of 5.2%.  It was the company’s 11th consecutive quarter of positive adjusted EBITDA. The standout performer was the eyeglasses business, which grew 44% year-over-year to $7.2 million in sales.

Kits delivered over 112,000 pairs of glasses during the quarter, representing a 53% increase from the prior year. Premium lens upgrades accounted for nearly 46% of glasses revenue and grew by 58% year-over-year, indicating that customers are increasingly choosing higher-value products. Returning customers now represent over 52,000 glasses deliveries, up 18% year-over-year.

Growth driven by AI and repeat business

Revenue originating from Canada increased by 44%, driven by new and returning customers across various product categories. Management noted this growth came despite Kits still having minimal market presence and brand awareness in most Canadian regions, suggesting a significant runway ahead.

The company added a record 111,000 new customers during the quarter, up 55% year-over-year, bringing the two-year active customer base to over 991,000 people. New customers contributed over 39% of revenue. To support this growth, marketing spend increased to 15.2% of revenue from 13.4% the previous year, reflecting strategic investments in customer acquisition programs, such as “first pair free” promotions.

Gross margins expanded 350 basis points year-over-year to 36.3%, benefiting from a higher glasses mix and improved operational efficiency. Management reiterated its long-term target of reaching 45% gross margins within three to five years, with adjusted EBITDA margins eventually reaching 15% to 20%.

Kits also launched OpticianAI during the quarter, a tool that helps customers select frames based on their unique measurements, prescription, and style preferences. Early feedback suggests customers view the online experience as superior to traditional retail for frame fitting.

For the third quarter, Kits expects revenue to be between $52 million and $54 million, with adjusted EBITDA margins of 5% to 7%, implying continued momentum in both growth and profitability.

Is the TSX stock undervalued?

Analysts tracking KITS stock forecast sales to rise from $159.3 million in 2024 to $356.6 million in 2027. Comparatively, adjusted earnings per share are estimated to expand from $0.04 to $0.48 in this period.

Moreover, free cash flow is projected to improve from $10 million in 2024 to $30 million in 2027. If the TSX stock is priced at 35 times forward FCF, it should double over the next 18 months.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kits Eyecare. The Motley Fool has a disclosure policy.

More on Tech Stocks

Retirees sip their morning coffee outside.
Tech Stocks

2 Technology Stocks With the Kind of Potential That Could Make Millionaires

Two tech stocks with impressive growth trajectories amid elevated volatility are potential millionaire-makers.

Read more »

Canada day banner background design of flag
Dividend Stocks

4 Canadian Stocks to Buy With $1,000 (No Stress Required)

These four TSX names aim for “sleep-well” compounding, mixing steady cash flow with growth you don’t have to babysit.

Read more »

up arrow on wooden blocks
Dividend Stocks

1 Discounted Canadian Dividend Stock Down 17% That’s Worth Buying Now

A high-yield but beaten-down Canadian dividend stock is a quality sale right now.

Read more »

Happy golf player walks the course
Tech Stocks

Could This $97 TSX Stock Be Your Ticket to Millionaire Status?

Topicus looks like a “boring millionaire-maker” by compounding cash flow through steady software acquisitions across Europe.

Read more »

Printing canadian dollar bills on a print machine
Tech Stocks

The 5 Top Canadian Stocks to Buy With $10,000 in 2026

Five TSX names could help turn a simple $10,000 start into a diversified 2026 portfolio across fast growth and steadier…

Read more »

Abstract technology background image with standing businessman
Tech Stocks

2 Canadian Growth Stocks That Could Make a Big Move in the Next Year

Investors with a long investment horizon might want to consider adding these two TSX growth stocks to their self-directed portfolios…

Read more »

stock chart
Tech Stocks

1 Canadian Tech Stock Down 45% That I’d Buy Today and Hold for the Long Haul

This overlooked software-focused tech stock still has strong fundamentals beneath the surface.

Read more »

chip glows with a blue AI
Tech Stocks

A Rare Investment Opportunity: The AI Stock I’d Most Want to Buy Right Now 

Get insights into the future of AI stocks as new technologies emerge and traditional players adapt in the market.

Read more »